The interactions between eight fluoroquinolone antibiotics (ciprofloxacin, enoxacin, fleroxacin, levofloxacin, lomefloxacin, norfloxacin, ofloxacin, pefloxacin) and bovine serum albumin (BSA) were studied by affinity capillary electrophoresis (ACE). The binding constants were estimated by the change of migration times of the analytes through the change of concentration of BSA in the buffer solution. The yield binding constants were between 3.19 × 10 4 and 1.21 × 10 5 M -1 . These were related with the structures of fluoroquinolones, and agreed with the results obtained by other techniques. The obtained binding constants may help us in gaining some insights on possible drug/protein interactions and in early evaluation of the drugs' pharmacokinetic profiles during drug discovery.
Introduction
The group of fluoroquinolones is one of the most successful classes of antibacterial drugs. These compounds are of exceeding interest because their clinical role has greatly expanded since they were introduced in the 1980s. Their activities result from the inhibition of different kinds of enzymes, such as homologous type II topoisomerase, DNA gyrase and DNA topoisomerase IV, which control DNA topology and are vital for chromosome function and replication. 1 Fluoroquinolones have been applied in the empirical treatment of a variety of infections, particularly those of genitourinary, gastrointestinal and respiratory tracts. 2 The relatively easy route to the chemical synthesis has led to rapid development of novel fluoroquinolones since 1989. [3] [4] [5] Different techniques have been applied in the study of biological interaction and metabolism of those compounds, and the obtained information would be very helpful for further drug discovery.
Protein binding has long been considered one of the most important physicochemical characteristics of drugs, playing a potential role in distribution, excretion and therapeutic effectiveness. 5 Protein binding of fluoroquinolones is a complex system, and it is very important to understand the therapeutic effectiveness and tolerability of fluoroquinolones. The binding constant (Kb) of fluoroquinolones with proteins is one of the most important parameters in evaluating the drugs' pharmacokinetic profiles. The fluorescence has been reported by Vargas' group 6 who studied the covalent photobinding characteristics of ciprofloxacin, norfloxacin, and enoxacin using human serum albumin as a model protein. The interaction between BSA and several fluoroquinolones by means of fluorescence quenching has also been reported. 7, 8 The mechanism of interaction between norfloxacin and ciprofloxacin with BSA has been investigated using circular dichroism, fluorescence and absorption spectroscopy by Kamat's group. 9 However, there is still a lack of information about a possible interaction of fluoroquinolones with the plasma albumins. The data of the binding constants of this interaction system have rarely been reported.
Affinity capillary electrophoresis (ACE) has been shown to be an efficient and accurate tool in studying biomolecular noncovalent interactions and determining binding constants of formed complexes. [10] [11] [12] ACE has several advantages, besides its speed and flexibility: a) only a small amount of protein and drug is required; b) non-purified sample can be injected directly; c) binding constants of several samples can be simultaneously estimated; d) all interaction components can be studied in free buffer solution at so-called physiological conditions. Our group has demonstrated a simple calculation method to estimate the binding constant of ligand to receptor in ACE based on the theories of capacity factor and pseudo-stationary phase. 13 The weak interactions between several anti-HIV active compounds with HIV TAR (trans-activation response) RNA, 14, 15 and the binding of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase to an octapeptide interface inhibitor 16 have been investigated. This method was proved to be feasible for study on the non-covalent interactions between small molecular ligands and biomacromolecules. In this research, we utilized this simple ACE method to study the interaction between eight fluoroquinolones (ciprofloxacin, enoxacin, fleroxacin, levofloxacin, lomefloxacin, norfloxacin, ofloxacin, pefloxacin) and BSA. The binding constants of the interaction systems were determined. The obtained data may help us in gaining some insights on a possible drug/protein interaction. norfloxacin, ofloxacin, pefloxacin were purchased from National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). The chemical structures of these small molecules are shown in Fig. 1 . BSA (RIA grade, Fraction V, Minimum 96%) was purchased from Sigma Chemical Co. (St. Louis, MO, USA). All other reagents were of analytical grade; they were purchased from standard reagent suppliers and used without further purification. Deionized water was used throughout.
Apparatus
All experiments were performed on a Beckman P/ACE 5000 system (Fullerton, CA, USA). Data acquisition was done with Beckman System Gold software. The capillary (Yongnian Optical Fibers, Yongnian, Hebei, China) was of uncoated fusedsilica 50 μm i.d., 50 cm from inlet to detector and 7 cm from detector to outlet. The capillary chamber temperature was thermostated at 20.0 ± 0.1˚C by forced liquid cooling. A run voltage of +18 kV in the normal polarity mode was applied. The separation was monitored at 280 nm.
Solution and sample preparation
Stock solutions of each of the eight compounds were prepared by first dissolving the compound in hydrochloric acid, then diluting the solution by phosphate buffered saline (PBS, pH 7.4; 100 mmol/L) (1:1, v/v). BSA stock solution (0.04 mmol/L) was prepared by dissolving the powder of definite weight in deionized water. The running buffer in the CE experiments was 0.05 mol/L sodium phosphate (40.5 mmol/L Na2HPO4 and 9.5 mmol/L NaH2PO4, pH 7.4). The investigated compounds and BSA solution were prepared by diluting the stock solution with the running buffer.
The constant concentrations of the investigated ciprofloxacin, enoxacin, fleroxacin, levofloxacin, lomefloxacin, norfloxacin, fleroxacin, pefloxacin were 3.33 × 10 -4 , 5.00 × 10 -4 , 5.00 × 10 -4 , 7.50 × 10 -4 , 3.33 × 10 -4 , 3.60 × 10 -4 , 3.00 × 10 -4 , 5.00 × 10 -4 M, respectively. Acetone served as the electroosmotic flow (EOF) marker and was added to the sample solution at a constant concentration of 2% (v/v). The varying concentrations of BSA in the running buffer were prepared from 0 to 18 μM. All solutions were stored at 4˚C, being filtered through 0.22 μm cellulose acetate membrane filters (Shanghai Xingya Resin, Shanghai, China) and sonicated for 10 min to remove air from solution prior to use.
Procedures
The sample solution was introduced into the capillary by pressure injection (0.5 psi for 10 s). The electrophoresis was carried out using a phosphate buffer (pH 7.4, 50 mM) containing different accurate concentrations of BSA (0 -18 μM). Between measurements, the capillary was flushed for 6 min with 0.2 M NaOH, 2 min with water, and 3 min with running buffer. All separations were in triplicate. The relative standard deviation (RSD) of migration time was calculated from a series of three experiments carried out with the same sample.
Results and Discussion

Quantitative model of the binding assays
In this experiment, after one adds BSA to the running buffer, it can interact with the drugs, and the equilibrium represents by the following equation assumes that a 1:1 complex is formed: 17 FQ + BSA ?
Kb
where FQ and FQ-BSA are the investigated fluoroquinolone and the complex, respectively. Kb is the binding constant for Eq. (1). As pointed out by Yang et al., 13 the capacity factor k, which is used as an indicator to describe the relationship between retention time and mass distribution equilibrium in chromatography, can be utilized here to describe the migration behaviors of the receptor in CE. Moreover, the addition of the ligand in the running buffer is applied as a pseudo-stationary phase. From the definition of k, the following equation could be obtained:
where K is the concentration ratio of the receptor in the stationary phase and the mobile phase, (Vs/Vm) is called the phase ratio, φ, and s indicates stationary phase and m indicates mobile phase. After the ligand is added to the running buffer, part of the receptor will bind to the ligand, resulting in the decrease of [FQ]m and the change of k. Based on the theories of pseudo-stationary phase and our previous studies, 13 Kb can be measured according to the following equation:
where φ is phase ratio, [FQ]s is the concentration of the fluoroquinolones binding with BSA, and [FQ]m0 is the initial concentration of the fluoroquinolones without BSA addition in the running buffer. As defined in chromatography, the capacity factor k is equal to (tr -t0)/t0, where tr and t0 are the migration times of the receptor and the neutral marker, respectively. Thus, in the interaction between fluoroquinolones and BSA, t and t0 are the migration times of the fluoroquinolone and neural marker (acetone), respectively. With a linear relationship of k versus the concentration of BSA ([BSA]), Kb is calculated from the slope and intercept, consequently.
Optimization of CE parameters and determination of the binding constants
In this work, buffer type, buffer concentration and pH used for ACE were firstly optimized.
In order to evaluate the pharmacological activity of fluoroquinolones binding to protein in a simulated physiological system, we used the sodium phosphate buffer system of 50 mM at pH 7.4 for the binding study. UV detection was at 280 nm according to the UV spectra of the eight drugs (Fig. 2) . The migration times of each drug (t) and acetone (t0) were measured in seven running buffer solutions containing different concentrations of BSA (0 -18 μM). The reproducibility of migration time was good (RSD 0.01 -2.3%). Figure 3 showed a representative set of electropherograms of migration time shift of the levofloxacin versus BSA concentration change at constant temperature, capillary length and voltage.
The electropherograms of the other seven drugs had the same elution pattern (data not shown).
Upon addition of increasing concentrations of BSA in the running buffer, both drug and acetone peaks shifted to the right. When the concentration of BSA was successively increased, the viscosity of the running buffer and the interaction with the capillary wall had changed, causing the shift of EOF. The migration of acetone represented the shift of EOF. k was calculated as (t -t0)/t0, thus, the effect of the variation of EOF was effectively eliminated. The complexation between small molecule and BSA resulted in an increasing m/z and the complex was detected later than the uncomplexed form. The migration time interval between drug and acetone was gradually enlarged with the successive increase of BSA concentration in the running buffer, resulting from the escalatory interaction between drug and BSA. The binding constants of the drugs with BSA were calculated according to Eq. (3). The good linearity of the plots was obtained, correlation coefficients (r) of which were from 0.92 to 0.98 (Fig. 4) . The corresponding linear equations, correlation coefficients and the binding constants of eight drugs were summarized in Table 1 .
The good linearity of the plots obtained for all the drugs showed that all data fitted well to a 1:1 drug/protein model. The binding constants were about 10 4 -10 5 M -1 level, consistent with the values reported earlier, showing that there was a relatively strong interaction between all the drugs and the protein. The difference of Kb obtained by ACE technique and other assays [6] [7] [8] 13 may be due to two reasons: (i) the different experiment conditions used in these methods, such as buffer pH values, ionic strength, temperature etc.; (ii) the different principles of these methods for determination of the binding constants. The binding constants of ciprofloxacin, enoxacin, fleroxacin, lomefloxacin, norfloxacin, pefloxacin were very similar at the same temperature.
This means that the interactions between these six drugs and BSA were similar due to somewhat similar chemical structure. Differences in the moiety present at N-1 position or at C-7 position markedly influenced both microbiological and pharmacokinetic properties. 18 The epoxy structure specially exists in levofloxacin and ofloxacin. The relatively stronger interaction of these two compounds with BSA may partially come from the structural differences. The interaction between the fluoroquinolones and BSA related to the chemical structures of the drugs and drugs may interact with BSA at the important position. The obtained information would be helpful in early evaluation of the drugs' pharmacokinetic profiles during drug discovery. 
Conclusions
Protein binding of a drug significantly affects the disposition and the strength of its pharmaceutical effects. The binding constant (Kb) is one of the most important parameters in evaluating the drugs' pharmacokinetic profiles. The binding constants of the drugs and BSA were determined easily by a simple ACE method. The values were all at the magnitude level of 10 4 -10 5 M -1 . There was a lack of information about the binding constants of the investigated fluoroquinolones and BSA, and the data obtained in this paper helped us in gaining some insights on a possible drug/protein interaction. 
